<DOC>
	<DOCNO>NCT01991041</DOCNO>
	<brief_summary>This registry study , site enter patient LGS require modification anti-epileptic therapy ( either addition another anti-epileptic drug , change one drug another ) . This include patient start rufinamide . Patients review accord local practice , envisage review occur approximately one month , three month six month , every six month . Upon entry registry baseline detail concern disease severity , diagnosis , prior therapy , developmental assessment record . On subsequent visit patient ( usually caregiver ) ask current medication , general seizure profile , seizures deem medical significance , tolerability , AEs ( include suicidal-related event ) , healthcare resource utilisation .</brief_summary>
	<brief_title>European Registry Anti-Epileptic Drug Use Patients With Lennox-Gastaut Syndrome ( LGS )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Lennox Gastaut Syndrome</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>INCLUSION CRITERIA Patients four year old Patients establish diagnosis LennoxGastaut syndrome , : Documented history current presence multiple seizure type associate LGS ( include tonic atonic seizure ( drop attack ) atypical absence ) Documented history current presence typical EEG abnormality ( e.g. , burst slow spike wave activity ) Presence intellectual / learning disability ( variable degree permit ) Patients enter registry require modification current antiepileptic medication . This include limited patient commence rufinamide adjuvant therapy EXCLUSION CRITERIA Female patient pregnant , lactating , plan become pregnant Female patient , child bear potential , willing use appropriate contraception ( This discretion investigator ) Those start rufinamide investigator considers necessary administer contradiction indication , warning within current Summary Product Characteristics ( SPC ) .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Lennox-Gastaut Syndrome</keyword>
</DOC>